Elevated Risk of Chronic Respiratory Conditions within 60 Days of COVID-19 Hospitalization in Veterans.
Elevated Risk of Chronic Respiratory Conditions within 60 Days of COVID-19 Hospitalization in Veterans.
复制标题
DOI：
10.3390/healthcare10020300
复制
发表时间：
2022-02-04
期刊：
影响因子：
--
通讯作者：
Sharafkhaneh A
中科院分区：
文献类型：
--
作者：
Park C;Razjouyan J;Hanania NA;Helmer DA;Naik AD;Lynch KE;Amos CI;Sharafkhaneh A
SARS-CoV-2 感染显着影响呼吸系统，因 COVID-19 住院的患者患呼吸系统疾病的风险增加。我们检查了 2020 年 2 月 15 日至 2021 年 6 月 16 日期间，国家退伍军人健康管理局住院患者中出现新的 COVID-19 呼吸道疾病的风险。研究队列包括所有接受过 COVID-19 检测、在入院前幸存且之前没有任何先前诊断出的慢性呼吸道疾病（哮喘、支气管炎、慢性肺病、慢性阻塞性肺病 (COPD)、肺气肿或静脉血栓栓塞）的住院患者。 SARS-CoV-2 测试。在 SARS-CoV-2 检测后住院的 373,048 名患者中，18,686 名阳性患者和 37,372 名阴性患者符合纳入/排除标准，并使用倾向评分匹配按年龄、性别和种族进行匹配。结果显示，SARS-CoV-2阳性人群在60天内患哮喘（调整比值比（aOR）= 1.37）、支气管炎（aOR = 2.81）、慢性肺病（aOR = 2.14）、COPD（aOR = 1.56）、肺气肿（aOR = 1.52）和静脉血栓栓塞（aOR = 1.92）的风险更大在索引新冠病毒测试日期之后。这些发现可以告知临床护理团队考虑新的呼吸系统疾病的风险，并在患者出院后的管理中解决这些疾病，这可能会降低并发症的风险并优化康复。
SARS-CoV-2 infection prominently affects the respiratory system, and patients hospitalized with COVID-19 are at an increased risk of developing respiratory conditions. We examined the risk of new respiratory conditions of COVID-19 among hospitalized patients in the national Veterans Health Administration between 15 February 2020 and 16 June 2021. The study cohort included all COVID-19-tested, hospitalized individuals who survived the index admission and did not have any previously diagnosed chronic respiratory conditions (asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), emphysema, or venous thromboembolism) before SARS-CoV-2 testing. Of 373,048 patients hospitalized after SARS-CoV-2 testing, 18,686 positive and 37,372 negative patients met the inclusion/exclusion criteria and were matched by age, sex, and race using propensity score matching. The results showed that the SARS-CoV-2 positive group had a greater risk of developing asthma (adjusted odds ratio (aOR) = 1.37), bronchitis (aOR = 2.81), chronic lung disease (aOR = 2.14), COPD (aOR = 1.56), emphysema (aOR = 1.52), and venous thromboembolism (aOR = 1.92) within 60 days after the index COVID date of testing. These findings could inform that the clinical care team considers a risk of new respiratory conditions and address these conditions in the post-hospitalization management of the patient, which could potentially lead to reduce the risk of complications and optimize recovery.
登录
查看更多内容
影响因子：
3.8
作者：
Robey RC;Kemp K;Hayton P;Mudawi D;Wang R;Greaves M;Yioe V;Rivera-Ortega P;Avram C;Chaudhuri N
通讯作者：
Chaudhuri N
影响因子：
4.6
作者：
Bhargava, Ankur;Kim, Tae;Hauser, Ronald George
通讯作者：
Hauser, Ronald George
影响因子：
5.8
作者：
Liu, Dehan;Zhang, Wanshu;Liang, Bo
通讯作者：
Liang, Bo
DOI：
10.1186/s13054-021-03639-w
发表时间：
2021-06-30
期刊：
Critical care (London, England)
影响因子：
--
作者：
de Roquetaillade C;Bredin S;Lascarrou JB;Soumagne T;Cojocaru M;Chousterman BG;Leclerc M;Gouhier A;Piton G;Pène F;Stoclin A;Llitjos JF
通讯作者：
Llitjos JF
DOI：
10.15585/mmwr.mm6942e3
发表时间：
2020-10-23
期刊：
MMWR. Morbidity and mortality weekly report
影响因子：
--
作者：
Cates J;Lucero-Obusan C;Dahl RM;Schirmer P;Garg S;Oda G;Hall AJ;Langley G;Havers FP;Holodniy M;Cardemil CV
通讯作者：
Cardemil CV